Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SECURE Post-Market Study

NCT: NCT07756489 · NOT_YET_RECRUITING

NCT IDNCT07756489
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2028-10
SponsorTissium (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this post-market study is to generate post-market, real- world evidence on the safety and performance of COAPTIUM® CONNECT with TISSIUM® LIGHT for the atraumatic sutureless repair of acute digital (sensory) injuries of the hand in adults through prospective data collection, to confirm safety and performance of the device.

Frequently Asked Questions

What is SECURE Post-Market Study?

SECURE Post-Market Study is a clinical trial registered under NCT07756489. Current status: NOT_YET_RECRUITING.

What is the status of NCT07756489?

The current status of NCT07756489 (SECURE Post-Market Study) is: NOT_YET_RECRUITING.

When did SECURE Post-Market Study start?

SECURE Post-Market Study started on 2026-10.

Related Devices

K251957Coaptium Connect with Tissium LightTissium SA

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑